Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response.
Nat Cancer. 2021 Apr;2(4):400-413. doi: 10.1038/s43018-021-00190-z. Epub 2021 Apr 8.
Nat Cancer. 2021.
PMID: 34966897
Free PMC article.
Transcriptome and genome evolution during HER2-amplified breast neoplasia.
Lu P, Foley J, Zhu C, McNamara K, Sirinukunwattana K, Vennam S, Varma S, Fehri H, Srivastava A, Zhu S, Rittscher J, Mallick P, Curtis C, West R.
Lu P, et al.
Breast Cancer Res. 2021 Jul 15;23(1):73. doi: 10.1186/s13058-021-01451-6.
Breast Cancer Res. 2021.
PMID: 34266469
Free PMC article.
Item in Clipboard
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).
Hurvitz SA, Caswell-Jin JL, McNamara KL, Zoeller JJ, Bean GR, Dichmann R, Perez A, Patel R, Zehngebot L, Allen H, Bosserman L, DiCarlo B, Kennedy A, Giuliano A, Calfa C, Molthrop D, Mani A, Chen HW, Dering J, Adams B, Kotler E, Press MF, Brugge JS, Curtis C, Slamon DJ.
Hurvitz SA, et al.
Nat Commun. 2020 Nov 17;11(1):5824. doi: 10.1038/s41467-020-19494-2.
Nat Commun. 2020.
PMID: 33203854
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite